Fibertab Side Effects
Generic name: polycarbophil
Medically reviewed by Drugs.com. Last updated on Mar 1, 2024.
Note: This document provides detailed information about Fibertab Side Effects associated with polycarbophil. Some dosage forms listed on this page may not apply specifically to the brand name Fibertab.
Applies to polycarbophil: oral tablet, oral tablet chewable.
Serious side effects of Fibertab
WARNING/CAUTION: Even though it may be rare, some people may have very bad and sometimes deadly side effects when taking a drug. Tell your doctor or get medical help right away if you have any of the following signs or symptoms that may be related to a very bad side effect:
- Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing, swallowing, or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.
- Chest pain or pressure.
- Upset stomach or throwing up.
- Trouble swallowing.
- Trouble breathing.
- Belly pain.
Other side effects of Fibertab
All drugs may cause side effects. However, many people have no side effects or only have minor side effects. Call your doctor or get medical help if you have any side effects that bother you or do not go away.
These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.
You may report side effects to the FDA at 1-800-332-1088. You may also report side effects at https://www.fda.gov/medwatch.
More about Fibertab (polycarbophil)
Patient resources
Other brands
FiberCon, Fiber Lax, Fiber Laxative, Equalactin, Konsyl Daily Fiber Therapy
Related treatment guides
Further information
Fibertab side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.